Anti-Denosumab Mouse Monoclonal Antibody [clone: 2H7]

Supplier: Genscript
A02101-40
77007-516EA 153.9 USD
77007-516
Anti-Denosumab Mouse Monoclonal Antibody [clone: 2H7]
Antibodies
Denosumab with trade name Prolia, is an FDA-approved drug for the treatment of patients with osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. Denosumab is a fully human monoclonal antibody that works as a RANK ligand (RANKL) inhibitor. Denosumab can bind RANKL, preventing RANKL from activating RANK, its receptor on the osteoclast surface. Anti-Denosumab Antibody (2H7), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with Denosumab.

  • High specificity
  • High affinity
  • High stability

GenScript has developed a broad range of off-the-shelf anti-idiotype antibodies against blockbuster drugs to help accelerate your research of biosimilars.

Type:
Antigen: Denosumab
Clonality: Monoclonal
Clone: 2H7
Conjugation:
Epitope:
Host: Mouse
Isotype: IgG1 kappa
Reactivity:
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR